Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New report sheds light on AMR bacteria in meat
The FSA says the risk of acquiring AMR-related infections is very low, assuming meat is cooked and handled correctly.
FSA study could inform future surveillance 

A new study has found antimicrobial resistance in a proportion of all types of bacteria examined in samples of chicken and pork.

The Food Standards Agency (FSA) tested 339 samples of raw chicken and 342 samples of raw pork mince from UK retailers. The findings will help to inform future surveillance of AMR in these foods.

Overall, resistance to the most clinically important antibiotics was generally seen more often in chicken than pork.

Key findings
  • A quarter of chicken samples tested positive for Campylobacter, of which 40.6 per cent were resistant to ciprofloxacin, 46.5 per cent to nalidixic acid and 61.4 per cent to tetracycline.
  • E. coli was detected in 49 per cent of chicken and 4.7 per cent of pork.
  • ESBL-producing E. coli was found in 10 per cent of retail chicken and 4.7 per cent of pork.
  • Klebsiella was detected in 37 per cent of pork mince samples and 6.5 per cent of chicken.
  • Enterococci was isolated more frequently from chicken (53 per cent) than pork mince (30 per cent). Resistance was rare with just one per cent of isolates resistant to vancomycin.
  • Salmonella was detected in 1.5 per cent of pork mince samples. All four isolates of S typhimurium were from the same processing plant. All were resistant to ampicillin and tetracycline and one to chloramphenicol. All had reduced susceptibility to sulfamethoxazole. The fifth isolate was identified as a strain of S Derby and had reduced susceptibility to sulfamethoxazole.

However, the FSA says the risk of acquiring AMR-related infections is very low, assuming meat is cooked and handled correctly.

Commenting on the findings, Steve Wearne, director of food policy at FSA, said: “The emergence and spread of AMR poses a significant global threat both in terms of public health and economic impact and we are determined to play our part in addressing this threat…

“As well as reducing antibiotic use on farms we also need to understand the role that food plays in AMR and we are working with the Quadram Institute in Norwich to understand how resistance arises and how resistant bacteria survive and are transmitted through the food chain.

"I am pleased that the food industry is also taking its stewardship role very seriously and is taking action on the O’Neill recommendations.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.